Suppr超能文献

核心减压与骨髓抽吸浓缩物注射治疗股骨头缺血性坏死:一项范围综述。

Core decompression and bone marrow aspirate concentrate injection for Avascular Necrosis (AVN) of the femoral head: A scoping review.

作者信息

Pawar Nishant, Vaish Abhishek, Vaishya Raju

机构信息

Department of Orthopaedics and Joint Replacement Surgery, Indraprastha Apollo Hospitals, Sarita Vihar, Mathura Road, New Delhi, 110076, India.

出版信息

J Clin Orthop Trauma. 2021 Nov 11;24:101691. doi: 10.1016/j.jcot.2021.101691. eCollection 2022 Jan.

Abstract

BACKGROUND

Various joint preserving treatments are available for use in Avascular Necrosis of the femoral head. Most of these are effective in the pre-collapse stage of the disease. This review aimed to evaluate the effectiveness of core decompression and Bone Marrow Aspirate Concentrate in various stages of AVN, in modifying the progression of the disease and the need for hip replacement.

MATERIAL AND METHODS

The Preferred Reporting Items for Systematic reviews and Meta-Analysis Extension for Scoping Reviews reporting guidelines were followed. The literature search was conducted from inception till 2 May 2021, on the PUBMED, SCOPUS, and Google Scholar search engines, using "bone marrow aspirate concentrate osteonecrosis femur" and "bmac osteonecrosis femur" as the keywords. In all these studies, Core Decompression with Bone marrow Aspirate concentrate was performed. The evaluation was done based on the progression of osteonecrosis, improvement in functional outcomes and the conversion to total hip arthroplasty.

RESULTS

We have analyzed 612 hips from11 studies, based on our inclusion and exclusion criteria. The mean age of the patients was 38.27 years. There was a predominance of males. The grade of AVN ranged from grade 1 to 4. The average follow-up period of the cases ranged from 2 to 12 years (average: 4.38 years). The functional scores were improved in the majority of cases. Radiographic progression occurred in 23.5% of hips, and the Total Hip Arthroplasty was performed in 14.9% of hips.

CONCLUSIONS

Core decompression with Bone Marrow Aspirate Concentrate in pre-collapse stages of the disease is beneficial in improving the functions scores and for reducing the radiological progression of the disease and need for total hip arthroplasty, in the majority of cases.

摘要

背景

股骨头缺血性坏死有多种保关节治疗方法可供选择。其中大多数在疾病的塌陷前期有效。本综述旨在评估髓芯减压和骨髓抽吸浓缩物在股骨头缺血性坏死各阶段对改变疾病进展和髋关节置换需求的有效性。

材料与方法

遵循系统评价和范围综述的系统评价与Meta分析扩展的首选报告项目报告指南。从数据库建立至2021年5月2日,在PubMed、Scopus和谷歌学术搜索引擎上进行文献检索,使用“骨髓抽吸浓缩物 股骨头坏死”和“bmac 股骨头坏死”作为关键词。在所有这些研究中,均采用了联合骨髓抽吸浓缩物的髓芯减压术。基于股骨头坏死的进展、功能结果的改善以及全髋关节置换术的转换情况进行评估。

结果

根据纳入和排除标准,我们分析了11项研究中的612个髋关节。患者的平均年龄为38.27岁。男性占多数。股骨头缺血性坏死的分级为1至4级。病例的平均随访期为2至12年(平均:4.38年)。大多数病例的功能评分有所改善。23.5%的髋关节出现影像学进展,14.9%的髋关节接受了全髋关节置换术。

结论

在疾病的塌陷前期,联合骨髓抽吸浓缩物的髓芯减压术在大多数情况下有利于改善功能评分、减少疾病的影像学进展以及降低全髋关节置换术的需求。

相似文献

引用本文的文献

本文引用的文献

2
Treatment of aseptic osteonecrosis of the femoral head: Historical aspects.股骨头无菌性坏死的治疗:历史方面。
Morphologie. 2021 Jun;105(349):102-119. doi: 10.1016/j.morpho.2021.02.003. Epub 2021 Mar 27.
9
Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment.股骨头坏死:病理生理学与当前治疗理念
EFORT Open Rev. 2019 Mar 15;4(3):85-97. doi: 10.1302/2058-5241.4.180036. eCollection 2019 Mar.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验